Immunology
Conference Coverage
Azithromycin prevents airway complications of antibody deficiency
MADRID – Low-dose azithromycin reduces airway complications in patients with primary antibody deficiencies.
Pearl of the Month
Does this patient have bacterial conjunctivitis?
After ruling out serious eye disease, clinicians need to determine which cases of suspected conjunctivitis are most likely to be bacterial.
From the Journals
Recombinant vaccine cut herpes zoster rate in immunocompromised patients
In a randomized clinical trial of 1,846 adults who had undergone autologous HSCT, herpes zoster cases were seen in 49 and 136 individuals in the...
Conference Coverage
Young lupus patients need more than medications
SAN FRANCISCO – Pilot studies demonstrate potential of web-based education and brief CBT to boost QOL and treatment adherence.
Conference Coverage
Dr. Douglas Paauw: Consider rechallenging patients with penicillin allergy
PHILADELPHIA – Penicillin allergies often are misdiagnosed.
Conference Coverage
Ligelizumab maintains urticaria control for up to 1 year
WASHINGTON – The open-label extension trial found a good maintenance of effect in patients with chronic spontaneous urticaria that is...
Conference Coverage
FDA panel calls for changes to breast implant rupture screening
The advisory panel seemed the current implant screening recommendation using MRI “useless.” They urged the adoption of ultrasound as a more...
Conference Coverage
Lentiviral gene therapy appears effective in X-CGD
HOUSTON – Results from the small study provide a “proof of concept” for the use of gene therapy in X-linked chronic granulomatous disease,...
Conference Coverage
Novel transplant regimen improves survival in primary immunodeficiency
HOUSTON – Allo-HCT following a novel reduced-intensity conditioning regimen was largely successful in an NIH study of adults and children with...
News
U.S. sesame allergy prevalence estimated at 750,000
SAN FRANCISCO – A representative U.S. sample of almost 80,000 adults and children showed a sesame allergy prevalence of 750,000 people.
From the Journals
Plerixafor produced dramatic responses in severe WHIM syndrome
The treatment was effective and well tolerated in patients who could not receive granulocyte colony-stimulating factor therapy.